Name

ALOMAD

Alternate names

None

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for ALOMAD

Name

Alternate Names

Actinomycin
Actinomycin AIV
Actinomycin C1
Actinomycin D
Actinomycin I1
Actinomycin IV
Actinomycindioic D-acid dilactone
Cosmegen
Dactino-mycin D
Meractinomycin
Oncostatin K

Abbreviations

ACD
ACT
ACT-D
ACTD
Acto-D
AD
Dact

Category

Chemotherapy

Subcategory

Antitumor antibiotic

NSC Number

003053
3053

Primary Site

Ewing's sarcoma
rhabdomyosarcoma
testicular cancer
Wilm's tumor

Histology

None

Remarks

FDA approved use on Ewing's sarcoma, rhabdomyosarcoma, gestational trophoblastic neoplasms, testicular carcinoma, Wilm's tumor (antitumor antibiotic)

Coding

This drug should be coded

Name

Alternate Names

Deticene
Detimedac
Dimethyl-triazeno-imidazole-carboxamide
DTIC-Dome
Fauldetic
Imidazole carboxamide
WR-139007

Abbreviations

DIC
DTIC
ICDT
ICT

Category

Chemotherapy

Subcategory

Antimetabolite
Nonclassic alkylating agent

NSC Number

45388
045388

Primary Site

Hodgkin's disease
melanoma
Neuroblastoma
Soft tissue sarcomas

Histology

None

Remarks

FDA approved on Hodgkin's lymphoma, and metastatic melanoma.

Coding

This drug should be coded

Name

Alternate Names

14-hydroxy-daunomycin
Adri-blastina (Italy)
Adriamycin
Adriamycin-TM
Caelyx
FT-106
Hydroxydaunomycin
Myocet
Pegylated Liposomal Doxorubicin Hcl
Rubex
S-DOX
Stealth(R) Liposomal Doxorubicin

Abbreviations

ADM
ADR
ADRI

Category

Chemotherapy

Subcategory

Antitumor antibiotic

NSC Number

123127

Primary Site

Bladder
breast
liver
multiple myeloma
ovarian
pancreatic
prostate cancer

Histology

None

Remarks

Phase II liver, pancreatic, Phase III MM, prostate Doxorubicin hydrochloride encapsulated in liposomes formulated with methoxypolyethylene glycol (MPEG). FDA approved use on bladder cancer, breast cancer, gastric cancer, leukemia, small cell lung cancer, lymphoma, neuroblastoma, ovarian cancer, sarcoma, thyroid cancer, Wilm's tumor. ALZA Corp, NeoPharm, Pharmacia, Schering-Plough, Sequus. Antitumor antibiotic

Coding

This drug should be coded

Name

Alternate Names

Ambochlorin
CB-1348
Chlorambucilum
Chloraminophene
Chlorbutin
Chlorbutine
Chlorbutinum
Ecloril
Leukeran
Leukersan
Leukoran
Linfilizin
Linfolysin
WR-139013

Abbreviations

CHL
CLB

Category

Chemotherapy

Subcategory

Alkylating agent

NSC Number

3088
003088

Primary Site

None

Histology

None

Remarks

A bifunctional alkylating antineoplastic agent. FDA approved uses on chronic lymphocytic leukemia, Hodgkins' and non-Hodgkin's lymphoma.

Coding

This drug should be coded

Name

Alternate Names

Amethopterin
Antifolan
CL-14377
Folex
Methotrexate Sodium
Mexate
Mexate AQ
Rheumatrex
WR-19039

Abbreviations

MTX

Category

Chemotherapy

Subcategory

Antimetabolite

NSC Number

740
000740

Primary Site

Acute lymphoblastic leukemia (ALL)
Bladder cancer
Breast
Gestational trophoblastic cancer
head & neck cancer
lymphoma
Meningeal leukemia
Non-Hodgkin lymphoma
Osteogenic sarcoma
Primary CNS lymphoma

Histology

None

Remarks

FDA approved uses on ALL, breast cancer, choriocarcinoma, head and neck cancer, lymphoma, and osteosarcoma.

Coding

This drug should be coded

Name

Alternate Names

Compound 37231
Leurocristine Sulfate
Oncovin
Vincasar
Vincasar PFS
Vincristine Sulfate
Vincrystine
Vinkristin

Abbreviations

LCR
VCR
VNCR

Category

Chemotherapy

Subcategory

Plant alkyloid--antimetabolite

NSC Number

067574
67574

Primary Site

None

Histology

None

Remarks

Antineoplastic; vinca plant alkaloid; antimetabolite. FDA approved uses in ALL, Hodgkin's lymphoma, non-Hodgkin's lymphoma, neuroblastoma, rhabomyosarcoma, and Wilm's tumor.

Coding

This drug should be coded
Glossary